86
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.012
Exchange
XHKG - Hong Kong Exchange
-1.442
Last period CFO / Debt ratio ,CNY
What is CFO / Debt ratio ?
CFO / Debt ratio is the ability of a company to pay off all of its debt obligations with cash generated from operating activities. The value 1 is the benchmark for Eyestock Rating calculation.
See also Huakang Biomedical
Company Analysis
8622.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
8622.HK financial analysis by Eyestock methodology
Valuation
8622.HK valuation using historical relative method
Statements
8622.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
8622.HK dividend yield and annual dividend
CFO / Debt ratio is the ability of a company to pay off all of its debt obligations with cash generated from operating activities. The value 1 is the benchmark for Eyestock Rating calculation.
Huakang Biomedical`s CFO / Debt ratio for the last twelve months ended 2024-06-30 is -1.442
